Health & Research Goals
Gut Repair Protocol
Protocolo de Reparación Intestinal
High-Performance Stack
Select a vial or the total
Primary Description
BPC-157 heals gastrointestinal mucosa and regulates the enteric nervous system. KPV reduces intestinal inflammation through NF-κB suppression. LL-37 provides antimicrobial defense and biofilm disruption. A comprehensive three-front gut health protocol.
Demonstrated Effects
- Gut Repair
- NF-κB
- Antimicrobial
- Mucosal
Proposed Mechanisms of Action
Combined Mechanism
BPC-157 (Body Protection Compound 157) heals the gut mucosal lining by activating VEGF-driven angiogenesis, normalizing GI motility via the nitric oxide pathway (eNOS upregulation), and upregulating growth factor receptors (EGF-R, FGFR) in intestinal epithelium — repairing intestinal permeability ("leaky gut") at the cellular level. KPV (Lys-Pro-Val tripeptide, C-terminal fragment of α-MSH) inhibits NF-κB nuclear translocation, specifically reducing IL-6 and TNF-α in intestinal epithelial and immune cells — targeted anti-inflammatory action directly at the GI mucosal layer. LL-37 (human cathelicidin antimicrobial peptide) provides broad-spectrum antimicrobial defense in the GI lumen, activates Toll-like receptor signaling to modulate innate immunity, and stimulates tight junction protein expression to reinforce the intestinal barrier.
Stack Compounds
Research Evidence & Clinical Data
Research Profile
BPC-157 heals GI mucosa. KPV reduces intestinal inflammation via NF-κB suppression. LL-37 provides antimicrobial defense and biofilm disruption. Complete gut-focused protocol.
Safety Profile
Common Side Effects
- Monitor for temporary changes in bowel habits during the first 1-2 weeks
- LL-37 may cause transient injection site discomfort
- Do not use if active systemic infection is present without medical supervision
- Reconstitute with bacteriostatic water and maintain cold chain
Contraindications
- Active inflammatory bowel disease flare requiring immunosuppression (LL-37 immune modulation may interfere)
- Known hypersensitivity to any component
- Active systemic infection
- Pregnancy
Analytical Quality Assurance
Research Protocols
Dosing Protocols
Combined Research Protocol: Protocolo de Reparación Intestinal
Sub-QMonitoring & Risk Management
Compound Stack Monitoring
For stacks and blends, refer to the individual compound monographs for each included ingredient for specific monitoring guidelines.